Product Information

TAMIFLU 6 MG/ML SUSPENSION is a brand product labeled by Genentech, Inc., priced at $2.4329 per ML under NDC 00004082205. Its NADAC has been published 508 times since Nov 28, 2013.

FDA first approved this application on Dec 14, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Oseltamivir Phosphate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

TAMIFLU 6 MG/ML SUSPENSION

Oseltamivir Phosphate
$2.4329per ML
High Outlier

Strength

6 mg/mL

Manufacturer

Genentech, Inc.

NDC

00004082205

Classification

Brand

Dosage Form

POWDER, FOR SUSPENSION

Route

ORAL

Effective Date

2/18/2026

Active Ingredients

OSELTAMIVIR PHOSPHATE

Approval Type

New Drug (NDA)

FDA Application

NDA021246

FDA Approved

12/14/2000

TE Code

AB

On Market Since

3/21/2011

Pharmacological Classes

Neuraminidase Inhibitor
Neuraminidase Inhibitors

Price Statistics

The NADAC for TAMIFLU 6 MG/ML SUSPENSION has been published 508 times since Nov 28, 2013, and over the history we have for it it has risen 42.9%. The table below summarizes its recorded NADAC range and movement.

Current price$2.4329 per ML
All-time high$2.4394 (Jan 10, 2024)
All-time low$1.7028 (Nov 28, 2013)
52-week high$2.4329
52-week low$2.4308
Median price$2.4249
Average price$2.2941
Largest weekly change+9.0% (Jul 9, 2014)
Weeks tracked508
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

+0.1%

3Y

-0.3%

5Y

-0.0%

All

+42.9%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 94% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TAMIFLU 6 MG/ML SUSPENSION?

The current National Average Drug Acquisition Cost (NADAC) for TAMIFLU 6 MG/ML SUSPENSION, manufactured by Genentech, Inc., is $2.4329 per ML (NDC 00004082205), effective Aug 19, 2026.

How has the price of TAMIFLU 6 MG/ML SUSPENSION changed over time?

Over the history we have for it, the NADAC for TAMIFLU 6 MG/ML SUSPENSION has risen 42.9%. It has been tracked across 508 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for TAMIFLU 6 MG/ML SUSPENSION?

Since Nov 28, 2013, the NADAC for TAMIFLU 6 MG/ML SUSPENSION has ranged from a low of $1.7028 (Nov 28, 2013) to a high of $2.4394 (Jan 10, 2024), with a median of $2.4249 per ML.

Are there cheaper alternatives to TAMIFLU 6 MG/ML SUSPENSION?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OSELTAMIVIR 6 MG/ML SUSPENSION, is $0.1511 per ML — about 94% below TAMIFLU 6 MG/ML SUSPENSION.

Who manufactures TAMIFLU 6 MG/ML SUSPENSION?

TAMIFLU 6 MG/ML SUSPENSION (NDC 00004082205) is labeled by Genentech, Inc., and CMS classifies it as a brand product.